Technical Meeting:

Accelerating HPV-related Cancer Elimination and HPV Faster

    Title
    Session 1: Welcome and introduction, Alex Vorsters
    9 downloads
    2 MB
    Session 2: Current landscape of HPV vaccination and the way towards elimination, Paul Bloem
    5 downloads
    2 MB
    Session 2: WHO Cervical Cancer Elimination Goals – increasing access to cervical cancer screening and treatment, Maribel Almonte
    5 downloads
    2 MB
    Session 3: HPV vaccination on HPV-positive women: Using functional in-vitro models to understand HPV infectivity and transmission, Miguel Ángel Pavón
    1 download
    6 MB
    Session 3: Investigations to understand HPV transmission among heterosexual couples: TRAP-HPV trial & HITCH cohort study, Eduardo Franco
    0 download
    1 MB
    Session 3: Research insights on latency, immune control and subclinical infection, John Doorbar
    0 download
    18 MB
    Session 3: Research insights on latency, immune control and subclinical infection, Patti Gravitt
    0 download
    2 MB
    Session 3: Understanding local HPV-related immunity using First Void Urine (FVU), Laura Téblick
    1 download
    7 MB
    Session 4: Accelerating HPV related cancer elimination: Bhutan’s Cervical Cancer Elimination Flagship program (as an example from LMIC), Pempa Pempa
    1 download
    2 MB
    Session 4: Enhancing HPV elimination efforts in Israel, Jacob Bornstein
    1 download
    3 MB
    Session 4: HPV Faster implementation in Mexico: A pilot study, Jorge Salmerón
    1 download
    1 MB
    Session 4: Targeting FASTER to reduce HPV reproductive rates: “Even Faster”, Joakim Dillner
    0 download
    1 MB
    Session 5: Research and implementation opportunities to accelerate cervical cancer prevention in Costa Rica, Aimee Kreimer
    0 download
    652 KB
    Session 6: Effective HPV vaccine dose reallocation given recent single dose recommendation & increased supply and manufacturers, Irene Man
    1 download
    2 MB
    Session 6: Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modelling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence, Ruanne Barnabas
    0 download
    2 MB
    Session 6: Rethinking Cervical Cancer Elimination Goal Indicators: From ASR to Lifetime risks, Eduardo Franco
    1 download
    1 MB
    Session 7: Considerations of HPV Faster strategy in at-risk populations, Marc Bardou
    0 download
    5 MB
    Session 7: Overview on IARC’s projects targeting at-risk population, Iacopo Baussano
    0 download
    2 MB